Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12188/7234| Title: | Expenditures on Oncology Drugs and Cancer Mortality-to-Incidence Ratio in Central and Eastern Europe | Authors: | Vrdoljak, Eduard Bodoky, Gyorgy Jassem, Jacek Popescu, Razvan Pirker, Robert Čufer, Tanja Bešlija, Semir Eniu, Alexandru Todorović, Vladimir Kopečková, Katerina Kurteva, Galia Tomašević, Zorica Sallaku, Agim Smichkoska, Snezhana Bajić, Žarko Sikic, Branimir |
Issue Date: | 2019 | Publisher: | Alphamed Press | Journal: | The Oncologist | Abstract: | There is a steady decline in cancer mortality in Western Europe (WE), but this trend is not so obvious in Central and Eastern Europe (CEE). One of the largest discrepancies between WE and CEE is the level of investment in cancer care. The objective of our analysis was to examine the correlation between mortality-to-incidence (M/I) ratio and expenditures on oncology drugs in CEE and WE. | URI: | http://hdl.handle.net/20.500.12188/7234 | DOI: | 10.1634/theoncologist.2018-0093 |
| Appears in Collections: | Faculty of Medicine: Journal Articles |
Show full item record
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.